Infliximab therapy intensification based on endoscopic activity is related to suppress treatment discontinuation in patients with Crohn disease: A retrospective cohort study

Administering double doses of infliximab or shortening its dosing interval for patients with Crohn disease who experience a loss of response to treatment is an accepted treatment method; however, the effectiveness and appropriate timing of treatment intensification remain unclear. We examined the tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Komaki, Yuga, Kanmura, Shuji, Yutsudo, Kazuki, Kuwazuru, Kosuke, Komaki, Fukiko, Tanaka, Akihito, Nishimata, Nobuaki, Sameshima, Yoichi, Sasaki, Fumisato, Ohi, Hidehisa, Nakamura, Yuichi, Tokushige, Koichi, Sameshima, Yukinori, Ido, Akio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545267/
https://www.ncbi.nlm.nih.gov/pubmed/33578618
http://dx.doi.org/10.1097/MD.0000000000024731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545267/
https://www.ncbi.nlm.nih.gov/pubmed/33578618
http://dx.doi.org/10.1097/MD.0000000000024731

Ejemplares similares